Last updated: April 23, 2026
What companies supply salmon calcitonin used in drugs?
Suppliers fall into three buckets: (1) active pharmaceutical ingredient (API) manufacturers for “salmon calcitonin,” (2) branded finished-dose owners/marketers, and (3) regional generic manufacturers and packagers that source API and manufacture finished products.
Which API manufacturers are documented suppliers of salmon calcitonin?
The API supply chain for salmon calcitonin is concentrated among established peptides and sterile injectables players. Documented suppliers include:
| Supply role |
Company |
Evidence type |
Notes |
| API manufacturer |
Chongqing Lummy Pharmaceutical Co., Ltd. |
Regulatory and product documentation trail |
Produces peptide APIs including calcitonin forms used in injectable markets. |
| API manufacturer |
Shanghai Era Biotech Co., Ltd. |
Regulatory and product listing trail |
Supplies peptide actives including calcitonin variants. |
| API manufacturer |
Pine Biotech Co., Ltd. |
Supplier listings |
Manufactures peptide actives; commonly listed as calcitonin-supplier for pharma markets. |
| API manufacturer |
Bachem AG |
Commercial peptide supplier |
Broad calcitonin portfolio historically; supplies peptides to pharma customers. |
| API manufacturer |
Selleck Chemicals / peptide catalog suppliers |
Catalog evidence |
Not always “API DMF-level” for global markets, but supplies calcitonin salmon for R&D and some production channels. |
Which branded finished-dose marketers source salmon calcitonin (by market presence)?
Branded salmon calcitonin products historically used in multiple jurisdictions are marketed by major pharma in partnership with manufacturing sites that buy API or produce drug substance and drug product under licensed arrangements.
| Market-facing role |
Company |
Example brand presence |
Typical supply structure |
| Branded marketer/owner |
Novartis |
Historical calcitonin franchises |
Uses internal and partner manufacturing; sources calcitonin salmon API or produces through controlled supply chain. |
| Branded marketer/owner |
Lundbeck |
Historical presence in calcitonin therapeutics |
Uses licensed manufacturing and supplier networks for peptide API and sterile products. |
Which generic manufacturers are active in salmon calcitonin finished products?
Generic supply is fragmented by geography but tends to cluster around sterile injectables platforms. Common finished-dose manufacturers include:
- Mylan (generic calcitonin products in some markets via partner manufacturing)
- Sandoz (generic injectables through sterile product networks)
- Teva (generic injectables via established sterile and API sourcing pipelines)
- Hospira/Pfizer supply chain (where applicable by legacy sterile portfolio sourcing)
- Local EU and MENA sterile manufacturers (license-to-manufacture models using imported API)
What do buyers typically require from salmon calcitonin suppliers?
Commercial qualification for salmon calcitonin is driven by peptide identity and sterility/particle control for injectables. Buyers typically specify:
How does sourcing differ between API and finished product?
| Buyer objective |
Preferred supplier path |
Typical contracting model |
| Launch or expand a branded/innovator finished product |
API + sterile manufacturing partners |
Parallel sourcing of API and sterile fill-finish under quality agreements |
| Build a generic sterile injectable |
Finished-dose manufacturers (or contract manufacturing) |
API sourced per qualified vendors; contract fill-finish and QC testing |
| Create research material / dose-finding |
Catalog peptide suppliers |
Non-DMF commercial peptide supply; later transition to DMF-grade for clinical |
What supply-chain risks matter for salmon calcitonin?
Salmon calcitonin is a peptide with sourcing and process consistency issues that show up in:
- Polypeptide supply constraints (lot-to-lot analytical variability risk)
- Sterile injectables platform capacity (fill-finish bottlenecks)
- Regulatory compliance cadence (site inspections and dossier updates)
- Market availability volatility (older therapies have sporadic production runs)
These risks translate into procurement controls:
- dual-source qualification,
- incoming COA review with predetermined acceptance,
- stability program alignment to the target shelf life.
Key takeaways
- Salmon calcitonin sourcing is concentrated among established peptide/API and sterile injectables supplier networks.
- Documented API suppliers include Chongqing Lummy Pharmaceutical Co., Ltd., Shanghai Era Biotech Co., Ltd., Pine Biotech Co., Ltd., and peptide specialists such as Bachem AG, with catalog suppliers like Selleck Chemicals also present in the market.
- Finished-dose supply is typically executed by generic and branded sterile manufacturing ecosystems (e.g., Novartis and other legacy pharma partners; Sandoz/Teva/Mylan-type generic networks depending on jurisdiction and product history).
- Buyers prioritize peptide identity/purity specs for API and sterility/particulate/endotoxin controls for finished injectables, backed by DMF/GMP and robust batch traceability.
FAQs
1) Are salmon calcitonin suppliers the same as “calcitonin” suppliers?
No. “Calcitonin salmon” is a specific peptide form; many suppliers carry multiple calcitonin types, but qualification and specs differ by source and formulation.
2) Do API suppliers provide DMF-grade salmon calcitonin?
Some do; others sell mainly for research or commercial supply. For regulated manufacturing, buyers rely on dossier support (DMF or equivalent) and GMP qualification of the API site.
3) What drives supplier selection for salmon calcitonin injectables?
Peptide purity and related substances in the API, and sterile injectables controls in finished products (sterility assurance, endotoxin, particulate control).
4) Can generic manufacturers use multiple API sources for salmon calcitonin?
Yes, once each source is qualified and validated to the same specification and impurity profile, with change control aligned to regulatory expectations.
5) Is there a single global supplier for salmon calcitonin?
No. Supply is regional and contract-based, with different qualified sources by jurisdiction and manufacturing site.
References
[1] U.S. Food and Drug Administration. (n.d.). Drug registration and listing data (search portal). FDA. https://www.accessdata.fda.gov
[2] European Medicines Agency. (n.d.). Medicines and related databases (public product and regulatory information). EMA. https://www.ema.europa.eu
[3] World Health Organization. (n.d.). Quality control of peptides and injectable products (general guidance materials). WHO. https://www.who.int
[4] Bachem AG. (n.d.). Calcitonin salmon product and peptide supply catalog (company information). Bachem. https://www.bachem.com
[5] Selleckchem. (n.d.). Calcitonin salmon catalog listing (company product information). Selleck Chemicals. https://www.selleckchem.com
